BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Biotech Beach

  Zavante Therapeutics To Present Fosfomycin For Injection Data At ASM Microbe 2018 Meeting

  Trade Name CONTEPO™ Selected for Zavante’s Investigational Antibiotic for Hospitalized Patients

  May 21, 2018

   · 

  7 min read
• Drug Development

  Precigen Announces First Patient Dosed in Phase 1 Clinical Study of INXN-4001

  Milestone represents the first ever triple effector gene therapy for heart failure

  May 21, 2018

   · 

  3 min read
• Biotech Bay

  New Data Reinforce Positive Impact of the Oncotype DX® Genomic Prostate Score™ Test in Guiding Treatment Decisions

  Studies in Over 30,000 Newly Diagnosed Prostate Cancer Patients Presented at American Urological Association (AUA) Annual Meeting Confirm Utility of GPS™ Test in Optimizing Cancer Care

  May 21, 2018

   · 

  6 min read
• BioCapital

  HealthCore Announces First-Time Direct Access to its Research Data for Improved Insights and Decision Making

  HIRD contains integrated longitudinal medical and pharmacy claims data for more than 48 million individuals and lab result data for more than 17 million individuals.

  May 21, 2018

   · 

  3 min read
• Business

  Galecto Biotech Strengthens Executive Team with Appointment of Richard Marshall as Chief Medical Officer

  Galecto Biotech AB, the leading developer of galectin modulators for the treatment of severe diseases, including fibrosis and cancer, today announced the appointment of Richard Marshall, MD, PhD, as Chief Medical Officer.

  May 21, 2018

   · 

  3 min read
• Business

  Journal of the American College of Radiology Names Dr. Ruth Carlos New Editor-in-Chief

  Dr. Carlos succeeds Bruce J. Hillman, MD, FACR, the founding editor of the JACR.

  May 21, 2018

   · 

  2 min read
• Pharm Country

  Baxter Highlights Business Strategies and Innovation at 2018 Investor Conference

  Company Increases Financial Guidance for 2020 and Provides Outlook for 2023

  May 21, 2018

   · 

  9 min read
• BioCapital

  As Firms Seek Cost-Effective Drug Manufacturing, Single-Use Processing Shines

  Users appreciate the flexibility and potential cost benefits of interchangeability.

  May 21, 2018

   · 

  3 min read
• Business

  Cidara Therapeutics and Rutgers University Awarded $5.5 Million Grant from NIH to Support Development of Novel Immunotherapy Agents Targeting Multi-drug Resistant Gram-negative Bacterial Infections

  New Partnership to Jointly Conduct Preclinical Development of Cidara’s Cloudbreak Antibody-Drug Conjugates

  May 21, 2018

   · 

  7 min read
• Drug Development

  Cerapedics Announces Presentation of Results from the IVANOS Study of i-FACTOR™ Peptide Enhanced Bone Graft in Uninstrumented Lumbar Posterolateral Spine Surgery

  Cerapedics, a privately-held orthobiologics company, today announced results from the IVANOS study evaluating i-FACTOR™ Peptide Enhanced Bone Graft in lumbar posterolateral spine surgery.

  May 21, 2018

   · 

  4 min read